Cited by 36Attention Deficit Hyperactivity DisorderPharmaceutical studies and practicesBehavioral and Psychological Studies

Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate‐release methylphenidate in the three ADHD subtypes

Open access
Chou, Wen‐Jiun, Chou, Miao‐Chun, Tzang, Ruu‐Fen, Hsu, Ya‐Chen, Gau, Susan Shur‐Fen, Chen, Shin‐Jaw, Wu, Yu‐Yu, Huang, Ya‐Fen +2 more·2009·Psychiatry and Clinical Neurosciences

Abstract

Aims: To determine factors for switching to osmotic release oral system methylphenidate (OROS‐MPH) among poor adherents to immediate‐release methylphenidate (IR‐MPH); and to compare the efficacy of OROS‐MPH on the three attention‐deficit/hyperactivity disorder (ADHD) subtypes in a multi‐site prospective observational study in Taiwan. Methods: The sample included 240 children with ADHD, aged 6–16 years, who were poor adherents to IR‐MPH, 137 of whom were switched to OROS‐MPH. The child psychiatrists diagnosed the Diagnostic Statistical Manual of Mental Disorders (4th edition) ADHD subtypes and assessed the medical history, adherence, side‐effects, global ADHD severity, and family/school effectiveness. Parents reported their child's behavioral symptoms. Results: The determinants for an OROS‐MPH switch were higher dosage, shorter treatment and thrice‐daily administration of IR‐MPH, and more severe inattention symptoms. Hyperactivity and oppositional symptoms were greater in the ADHD combined and hyperactive‐impulsive subtypes than the inattentive subtype. Switching to OROS‐MPH significantly improved behavioral symptoms and family/school measures, and this was most evident in the ADHD‐combined group, followed by the ADHD‐inattentive group. Inattention influenced not only academic performance, but also overall classroom behaviors and the parent–child relationship, with the latter two also influenced by oppositional symptoms. Conclusions: This study suggests better efficacy for the OROS‐MPH among poor adherents to IR‐MPH; however, its effectiveness varied across the three ADHD subtypes (ClinicalTrials.gov number NCT00460720).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1440-1819.2009.01937.x

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • OROS methylphenidate lessens ADHD symptoms throughout the day and has greater adherence, thought associated with convenience of once-daily dosing.

    “Research has continued to suggest that osmotic-release oral system (OROS) methylphenidate lessens ADHD symptoms throughout the day and has greater adherence, thought to be associated with the convenience of once-daily dosing [39-41].”

    From Advances in understanding and treating ADHD (2011) · cites this paper as [40]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. N. Z. J. Psychiatry 2003; 37: 570-576.

Cited by

Sorted by citations

Authors
Chou, W., Chou, M., Tzang, R., Hsu, Y., Gau, S. S., Chen, S., Wu, Y., Huang, Y., Liang, H., & Cheng, H.
Affiliations
  • Chang Gung University (TW)
  • Mackay Memorial Hospital (TW)
  • Taichung Hospital (TW)
  • National Taiwan University (TW)
  • National Cheng Kung University Hospital (TW)
  • Changhua Christian Hospital (TW)
Corresponding author
Gau, Susan Shur‐Fen
Venue
Psychiatry and Clinical Neurosciences
Publisher
Wiley
Published
2009-03-20
Volume
63
Issue
2
Pages
167-175
ISSN
  • 1323-1316 (ISSN-L)
  • 1440-1819
OpenAlex
W2132430593
Cited by
36
References
25
Citations by year
2026: 1 · 2024: 2 · 2021: 3 · 2020: 1 · 2018: 1 · 2017: 1 · 2015: 1 · 2014: 2 · 2013: 5 · 2012: 7
FWCI
3.92
Type
journal article
Language
en
Open access
Locations
  • Psychiatry and Clinical Neurosciences (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Health Research Institutes (NHRI-EX95, NHRI-EX95-9407PC)
  • Cilag
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
Keywords
immediate-release methylphenidate, medication adherence, ADHD subtypes, children, inattentive symptoms, hyperactivity, behavioral symptoms, parent-child relationship, academic performance
MeSH terms
Adolescent, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Child Behavior, Delayed-Action Preparations, Family Relations, Female, Humans, Male, Methylphenidate, Parents, Patient Compliance, Psychiatric Status Rating Scales, Psychomotor Performance, Schools, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review